Passage Bio Inc (PASG)
Stock chart
Loading...
•
Purchase
•
Sale
•
Planned purchase
•
Planned sale
Net purchase
Net sale
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2025-01-14 | 2025-01-14 | S Sale |
ORBIMED ADVISORS LLC Large shareholder |
1,000
-1.1%
0.60USD 47,414 |
1,000 -1.1% | 0.60 | USD 100,000 | |
| 2025-01-14 | 2025-01-13 | S Sale |
ORBIMED ADVISORS LLC Large shareholder |
1,000
-0.3%
0.64USD 11,511 |
1,000 -0.3% | 0.64 | USD 100,000 | |
| 2025-01-14 | 2025-01-10 | S Sale |
ORBIMED ADVISORS LLC Large shareholder |
1,000
-1.7%
0.66USD 83,298 |
1,000 -1.7% | 0.66 | USD 100,000 | |
| 2025-01-08 | 2025-01-08 | S Sale | Large shareholder |
1,000
-1.0%
0.68USD 51,005 |
1,000 -1.0% | 0.68 | USD 100,000 | |
| 2025-01-08 | 2025-01-07 | S Sale | Large shareholder |
1,000
-0.7%
0.71USD 37,301 |
1,000 -0.7% | 0.71 | USD 100,000 | |
| 2025-01-08 | 2025-01-06 | S Sale | Large shareholder |
1,000
-0.3%
0.77USD 15,000 |
1,000 -0.3% | 0.77 | USD 100,000 | |
| 2024-12-31 | 2024-12-27 | B Purchase | Large shareholder |
373,645
+4.2%
0.65USD 241,038 |
373,645 +4.2% | 0.65 | USD 241,038 | |
| 2024-12-26 | 2024-12-20 | S Sale | Large shareholder |
230,321
-3.0%
0.60USD 138,193 |
230,321 -3.0% | 0.60 | USD 138,193 | |
| 2024-12-11 | 2024-12-11 | S Sale | Large shareholder |
80
-0.0%
0.80USD 64 |
80 -0.0% | 0.80 | USD 64 | |
| 2024-12-11 | 2024-12-10 | S Sale | Large shareholder |
8,015
-0.1%
0.80USD 6,412 |
8,015 -0.1% | 0.80 | USD 6,412 | |
| 2024-12-11 | 2024-12-09 | S Sale | Large shareholder |
54,181
-0.7%
0.84USD 45,512 |
54,181 -0.7% | 0.84 | USD 45,512 | |
| 2024-12-06 | 2024-12-06 | S Sale | Large shareholder |
20,903
-0.3%
0.82USD 17,140 |
20,903 -0.3% | 0.82 | USD 17,140 | |
| 2024-12-06 | 2024-12-04 | S Sale | Large shareholder |
76,200
-1.0%
0.79USD 60,198 |
76,200 -1.0% | 0.79 | USD 60,198 | |
| 2024-11-27 | 2024-11-27 | B Purchase | Large shareholder |
29,300
+0.3%
0.67USD 19,663 |
29,300 +0.3% | 0.67 | USD 19,663 | |
| 2024-11-27 | 2024-11-26 | B Purchase | Large shareholder |
167,055
+1.9%
0.71USD 118,191 |
167,055 +1.9% | 0.71 | USD 118,191 | |
| 2024-11-27 | 2024-11-25 | B Purchase | Large shareholder |
259,998
+3.1%
0.56USD 146,665 |
259,998 +3.1% | 0.56 | USD 146,665 | |
| 2024-09-23 | 2024-09-19 | S Sale | Large shareholder |
39,300
-0.5%
0.71USD 27,903 |
39,300 -0.5% | 0.71 | USD 27,903 | |
| 2024-09-18 | 2024-09-18 | S Sale | Large shareholder |
25,631
-0.3%
0.73USD 18,711 |
25,631 -0.3% | 0.73 | USD 18,711 | |
| 2024-09-18 | 2024-09-17 | S Sale | Large shareholder |
111,400
-1.4%
0.73USD 81,322 |
111,400 -1.4% | 0.73 | USD 81,322 | |
| 2024-09-18 | 2024-09-16 | S Sale | Large shareholder |
63,100
-0.8%
0.74USD 46,694 |
63,100 -0.8% | 0.74 | USD 46,694 | |
| 2024-02-13 | 2024-02-13 | S Sale |
SVP, INTERIM CFO Officer |
1,470
-4.9%
0.97USD 1,426 |
1,470 -4.9% | 0.97 | USD 1,426 | |
| 2024-02-13 | 2024-02-13 | S Sale |
CHIEF MEDICAL OFFICER Officer |
1,638
-3.3%
0.97USD 1,589 |
1,638 -3.3% | 0.97 | USD 1,589 | |
| 2024-01-03 | 2024-01-02 | S Sale |
SVP, Interim CFO Officer |
10,672
-29.2%
0.91USD 9,712 |
10,672 -29.2% | 0.91 | USD 9,712 | |
| 2024-01-03 | 2024-01-02 | S Sale |
Chief Medical Officer Officer |
15,813
-25.9%
0.91USD 14,390 |
15,813 -25.9% | 0.91 | USD 14,390 | |
| 2024-01-03 | 2024-01-02 | S Sale |
GC & Corporate Secretary Officer |
15,813
-25.6%
0.91USD 14,390 |
15,813 -25.6% | 0.91 | USD 14,390 | |
| 2023-08-01 | 2023-07-28 | S Sale |
Chief Financial Officer Officer |
11,453
-32.3%
0.88USD 10,079 |
11,453 -32.3% | 0.88 | USD 10,079 | |
| 2023-06-29 | 2023-06-28 | B Purchase | Large shareholder |
575,195
+7.7%
0.84USD 483,164 |
575,195 +7.7% | 0.84 | USD 483,164 | |
| 2023-06-29 | 2023-06-27 | B Purchase | Large shareholder |
617,382
+9.0%
0.84USD 518,601 |
617,382 +9.0% | 0.84 | USD 518,601 | |
| 2023-06-20 | 2023-06-16 | S Sale |
Chief Technical Officer Officer |
4,052
-12.4%
0.93USD 3,778 |
4,052 -12.4% | 0.93 | USD 3,778 | |
| 2023-04-20 | 2023-04-18 | S Sale |
Chief Financial Officer Officer |
2,053
-50.0%
1.05USD 2,156 |
2,053 -50.0% | 1.05 | USD 2,156 | |
| 2022-12-02 | 2022-12-01 | PS Planned sale | Non-Executive Director |
5,000
-100.0%
1.19USD 5,965 |
5,000 -100.0% | 1.19 | USD 5,965 | |
| 2022-11-25 | 2022-11-22 | PS Planned sale |
Chief Technical Officer Officer |
3,720
-15.5%
1.33USD 4,948 |
3,720 -15.5% | 1.33 | USD 4,948 | |
| 2022-11-18 | 2022-09-19 | S Sale |
Chief Commercial Officer Officer |
1,681
-33.6%
1.51USD 2,539 |
1,681 -33.6% | 1.51 | USD 2,539 | |
| 2022-05-05 | 2022-05-04 | B Purchase | Large shareholder |
303,500
+4.6%
1.94USD 588,790 |
303,500 +4.6% | 1.94 | USD 588,790 | |
| 2022-05-05 | 2022-05-03 | B Purchase | Large shareholder |
221,500
+3.5%
1.93USD 427,495 |
221,500 +3.5% | 1.93 | USD 427,495 | |
| 2022-03-23 | 2022-03-21 | B Purchase |
CEO and President Executive Director |
10,000
+167.1%
3.15USD 31,500 |
10,000 +167.1% | 3.15 | USD 31,500 | |
| 2022-01-24 | 2022-01-20 | B Purchase | Large shareholder |
369,100
+5.9%
5.42USD 2,000,522 |
369,100 +5.9% | 5.42 | USD 2,000,522 | |
| 2022-01-20 | 2022-01-19 | B Purchase | Large shareholder |
43,300
+0.7%
5.11USD 221,263 |
43,300 +0.7% | 5.11 | USD 221,263 | |
| 2022-01-20 | 2022-01-18 | B Purchase | Large shareholder |
114,700
+1.9%
5.46USD 626,262 |
114,700 +1.9% | 5.46 | USD 626,262 | |
| 2022-01-20 | 2022-01-14 | B Purchase | Large shareholder |
10,300
+0.2%
5.60USD 57,680 |
10,300 +0.2% | 5.60 | USD 57,680 | |
| 2022-01-13 | 2022-01-13 | B Purchase | Large shareholder |
41,800
+0.7%
5.52USD 230,736 |
41,800 +0.7% | 5.52 | USD 230,736 | |
| 2022-01-13 | 2022-01-12 | B Purchase | Large shareholder |
100,000
+1.7%
5.65USD 565,000 |
100,000 +1.7% | 5.65 | USD 565,000 | |
| 2022-01-13 | 2022-01-11 | B Purchase | Large shareholder |
8,200
+0.1%
5.53USD 45,346 |
8,200 +0.1% | 5.53 | USD 45,346 | |
| 2021-05-21 | 2021-05-21 | PP Planned purchase |
CEO and President Executive Director |
2,000
+50.2%
13.12USD 26,230 |
2,000 +50.2% | 13.12 | USD 26,230 | |
| 2021-03-17 | 2021-03-15 | PS Planned sale |
Chief Medical Officer Officer |
1,617
-100.0%
21.86USD 35,350 |
1,617 -100.0% | 21.86 | USD 35,350 | |
| 2021-03-17 | 2021-03-15 | PS Planned sale |
Chief Medical Officer Officer |
8,383
-83.8%
20.95USD 175,662 |
8,383 -83.8% | 20.95 | USD 175,662 | |
| 2021-01-22 | 2021-01-20 | PS Planned sale |
Chief Operating Officer Officer |
1,300
-0.4%
30.01USD 39,011 |
1,300 -0.4% | 30.01 | USD 39,011 | |
| 2020-03-25 | 2020-03-24 | B Purchase | Non-Executive Director |
10,000
+112.4%
14.98USD 149,750 |
10,000 +112.4% | 14.98 | USD 149,750 | |
| 2020-03-03 | 2020-03-03 | B Purchase | Non-Executive Director |
5,000
+inf%
18.00USD 90,000 |
5,000 +inf% | 18.00 | USD 90,000 | |
| 2020-03-03 | 2020-03-03 | B Purchase |
Chief Technical Officer Officer |
5,500
+inf%
18.00USD 99,000 |
5,500 +inf% | 18.00 | USD 99,000 | |
| 2020-03-03 | 2020-03-03 | B Purchase |
Versant Venture Capital VI, L.P. Large shareholder |
225,000
+31.8%
18.00USD 4,050,000 |
225,000 +31.8% | 18.00 | USD 4,050,000 | |
| 2020-03-03 | 2020-03-03 | B Purchase | Non-Executive Director |
2,800
+inf%
18.00USD 50,400 |
2,800 +inf% | 18.00 | USD 50,400 | |
| 2020-03-03 | 2020-03-03 | B Purchase | Non-Executive Director Large shareholder |
550,000
+12.3%
18.00USD 9,900,000 |
550,000 +12.3% | 18.00 | USD 9,900,000 | |
| 2020-03-03 | 2020-03-03 | B Purchase |
Chief Financial Officer Officer |
400
+inf%
18.00USD 7,200 |
400 +inf% | 18.00 | USD 7,200 | |
| 2020-03-03 | 2020-03-03 | B Purchase | Non-Executive Director |
6,500
+1.0%
18.00USD 117,000 |
6,500 +1.0% | 18.00 | USD 117,000 | |
| 2020-03-03 | 2020-03-03 | B Purchase |
CEO and President Executive Director |
1,100
+inf%
18.00USD 19,800 |
1,100 +inf% | 18.00 | USD 19,800 | |
| 2020-03-03 | 2020-03-03 | B Purchase | Non-Executive Director Large shareholder |
225,000
+31.8%
18.00USD 4,050,000 |
225,000 +31.8% | 18.00 | USD 4,050,000 | |
| 2020-03-03 | 2020-03-03 | B Purchase |
GC and Corporate Secretary Officer |
2,000
+inf%
18.00USD 36,000 |
2,000 +inf% | 18.00 | USD 36,000 | |
| 2020-03-03 | 2020-03-03 | B Purchase |
Chief Operating Officer Officer |
1,000
+inf%
18.00USD 18,000 |
1,000 +inf% | 18.00 | USD 18,000 | |
| 2020-03-03 | 2020-03-03 | B Purchase |
Chief Operating Officer Officer |
1,500
+0.5%
18.00USD 27,000 |
1,500 +0.5% | 18.00 | USD 27,000 | |
| 2020-03-03 | 2020-03-03 | B Purchase | Non-Executive Director |
8,900
+inf%
18.00USD 160,200 |
8,900 +inf% | 18.00 | USD 160,200 | |
| 2020-03-03 | 2020-03-03 | B Purchase |
Frazier Life Sciences IX, L.P. Large shareholder |
550,000
+12.3%
18.00USD 9,900,000 |
550,000 +12.3% | 18.00 | USD 9,900,000 | |
| 2020-03-03 | 2020-03-03 | B Purchase | Non-Executive Director |
5,000
+inf%
18.00USD 90,000 |
5,000 +inf% | 18.00 | USD 90,000 | |
| 2020-03-03 | 2020-02-28 | B Purchase | Large shareholder |
373,300
+inf%
18.00USD 6,719,400 |
373,300 +inf% | 18.00 | USD 6,719,400 |